Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Basani, R.
Right arrow Articles by Poncz, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Basani, R.
Right arrow Articles by Poncz, M
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Glanzmann thrombasthenia due to a two amino acid deletion in the fourth calcium-binding domain of alpha IIb: demonstration of the importance of calcium-binding domains in the conformation of alpha IIb beta 3

RB Basani, G Vilaire, SJ Shattil, MA Kolodziej, JS Bennett and M Poncz

Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, USA.

The integrin alpha IIb beta 3, a calcium-dependent heterodimer, plays a critical role in platelet aggregation. The alpha IIb subunit of the heterodimer contains four highly conserved putative calcium-binding domains in its extracellular portion. During studies of the molecular basis of Glanzmann thrombasthenia in a child of mixed Caucasian background whose platelets expressed little alpha IIb beta 3 on their surface, we found the patient heterozygous for a two amino acid deletion in the fourth alpha IIb calcium-binding domain. When this alpha IIb mutant was expressed in COS-1 cells, we found that the deletion did not interfere with the assembly of alpha IIb beta 3 heterodimers, but altered their conformation such that they were neither recognized by the heterodimer-specific antibody A2A9 nor able to undergo further intracellular processing or transport to the cell surface. These results suggest that the calcium-binding domains in alpha IIb play an important role maintaining the overall conformation of alpha IIb beta 3. To confirm this suggestion, we deleted each of the four 12 amino acid calcium-binding domains in alpha IIb by in vitro mutagenesis and expressed the mutants along with beta 3 in COS-1 cells. Each construct formed a heterodimer with beta 3, but none of the heterodimers interacted with A2A9 or underwent further intracellular processing. These data indicate that the calcium-binding domains in alpha IIb are not involved in alpha IIb beta 3 heterodimer formation, but their presence is required for the intracellular transport of alpha IIb beta 3 to the cell surface.

Volume 88, Issue 1, pp. 167-173, 07/01/1996
Copyright © 1996 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
CLIN APPL THROMB HEMOSTHome page
M. Kannan and R. Saxena
Glanzmann's Thrombasthenia: An Overview
Clinical and Applied Thrombosis/Hemostasis, April 1, 2009; 15(2): 152 - 165.
[Abstract] [PDF]


Home page
BloodHome page
W. B. Mitchell, J. H. Li, F. Singh, A. D. Michelson, J. Bussel, B. S. Coller, and D. L. French
Two novel mutations in the alpha IIb calcium-binding domains identify hydrophobic regions essential for alpha IIbbeta 3 biogenesis
Blood, March 15, 2003; 101(6): 2268 - 2276.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
M. K. Boudreaux and D. L. Lipscomb
Clinical, Biochemical, and Molecular Aspects of Glanzmann's Thrombasthenia in Humans and Dogs
Vet. Pathol., May 1, 2001; 38(3): 249 - 260.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
D. L. Lipscomb, C. Bourne, and M. K. Boudreaux
Two Genetic Defects in {alpha}IIb Are Associated with Type I Glanzmann's Thrombasthenia in a Great Pyrenees Dog: A 14-base Insertion in Exon 13 and a Splicing Defect of Intron 13
Vet. Pathol., November 1, 2000; 37(6): 581 - 588.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. L. French and U. Seligsohn
Platelet Glycoprotein IIb/IIIa Receptors and Glanzmann’s Thrombasthenia
Arterioscler Thromb Vasc Biol, March 1, 2000; 20(3): 607 - 610.
[Full Text] [PDF]


Home page
BloodHome page
R. B. Basani, D. L. French, G. Vilaire, D. L. Brown, F. Chen, B. S. Coller, J. M. Derrick, T. K. Gartner, J. S. Bennett, and M. Poncz
A naturally occurring mutation near the amino terminus of alpha IIb defines a new region involved in ligand binding to alpha IIbbeta 3
Blood, January 1, 2000; 95(1): 180 - 188.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. J. Calvete
Platelet Integrin GPIIb/IIIa: Structure-Function Correlations. An Update and Lessons from Other Integrins2
Experimental Biology and Medicine, October 2, 1999; 222(1): 29 - 38.
[Abstract] [Full Text]


Home page
BloodHome page
R. B. Basani, D. L. Brown, G. Vilaire, J. S. Bennett, and M. Poncz
A Leu117 right-arrow Trp Mutation Within the RGD-Peptide Cross-Linking Region of beta 3 Results in Glanzmann Thrombasthenia by Preventing alpha IIbbeta 3 Export to the Platelet Surface
Blood, October 15, 1997; 90(8): 3082 - 3088.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1996 by American Society of Hematology         Online ISSN: 1528-0020